Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Cholangitis and intra-abdominal sepsis

Infectious diseases, microbiology and sexual health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Sepsis with an uncontrolled abdominal source

Hypotension, altered consciousness, rising lactate, oliguria or peritonism with biliary or abdominal infection signals time-critical organ dysfunction and possible obstruction or perforation.

Action: Use ABCDE, obtain cultures and lactate without delaying therapy, give guideline-concordant intravenous antimicrobials and fluids, and involve surgical, gastroenterology, radiology and critical-care teams immediately for source control.

Synopsis

Recognise biliary and intra-abdominal sepsis early, stabilise organ dysfunction, choose anatomy-directed imaging and achieve timely endoscopic, radiological or surgical source control.

  • Acute cholangitis is infection behind an obstructed biliary tree; antibiotics cannot reliably sterilise a pressurised system without drainage.
  • Charcot triad is fever, jaundice and right upper-quadrant pain, but its absence does not exclude cholangitis.
  • Take blood cultures before antibiotics when this does not delay treatment; bacteraemia is common and guides de-escalation.
  • Ultrasound is the usual initial biliary imaging test in a stable patient; CT better assesses perforation, abscess and alternative intra-abdominal sources.
  • Severe cholangitis requires urgent endoscopic or alternative biliary decompression coordinated with resuscitation and critical care.
  • Empirical antimicrobial choice is local because resistance, prior instrumentation, allergy and organ function materially alter safe coverage.
  • Perforation, anastomotic leak, devitalised bowel and abscess require prompt surgical or radiological source control rather than prolonged antibiotics alone.
  • Review antimicrobial therapy at 48 to 72 hours against cultures, procedure findings and adequacy of drainage.

Key red flags

Hypotension, rising lactate, confusion or oliguria indicates sepsis-related organ dysfunction.

Generalised guarding, rigidity or free intraperitoneal gas suggests perforation requiring immediate surgical assessment.

Jaundice with fever and right upper-quadrant pain suggests acute cholangitis from biliary obstruction.

Jaundice, sepsis, hypotension and altered consciousness indicates severe cholangitis requiring urgent drainage.

Persistent sepsis despite antimicrobial therapy suggests failed source control, resistant organisms or an alternative diagnosis.

Biliary inflammatory syndrome

Fever or rigors, jaundice and right upper-quadrant or epigastric pain support cholangitis, although older or immunocompromised adults may lack the full triad.

Severe cholangitis physiology

Hypotension, confusion, hypoxaemia, oliguria, coagulopathy or thrombocytopenia indicates organ dysfunction and demands urgent decompression and critical-care assessment.

Peritoneal inflammation

Involuntary guarding, rebound, rigidity, absent bowel sounds or pain worsened by movement suggests contamination, perforation or ischaemia.

Recent intervention clue

ERCP, biliary stent, abdominal surgery, drain manipulation or transplantation changes anatomy, organism probability and the urgency of specialist source control.

Investigation priorities

01
Blood cultures before antimicrobialsFirst step

Identify bacteraemia and susceptibility while preserving diagnostic yield.

Management branches

RESUSCITATETreat sepsis while defining source

Biliary or intra-abdominal infection is accompanied by abnormal physiology or organ dysfunction.

  1. Use ABCDE, measure lactate and glucose, secure intravenous access, monitor urine output and give oxygen and balanced crystalloid according to physiology.
  2. Obtain blood cultures promptly and begin intravenous antimicrobials within the sepsis pathway, adjusted for allergy, renal function, recent cultures and healthcare exposure.
  3. Request early senior, surgical or gastroenterology review and involve critical care for persistent hypotension, rising lactate or respiratory compromise.
  4. Reassess after every intervention and document the suspected anatomical source, planned imaging and latest acceptable time for drainage or operation.

Key medicines

Co-amoxiclav intravenous regimenGive 1.2 g intravenously every eight hours only when the local intra-abdominal guideline selects it, with renal adjustment as required.Check immediate penicillin allergy, liver injury history, renal function and local resistance; it may be inadequate after biliary instrumentation or with resistant previous isolates.
Cefuroxime plus metronidazoleWhere locally recommended, give cefuroxime 1.5 g intravenously every eight hours plus metronidazole 500 mg intravenously every eight hours.Clarify beta-lactam allergy, adjust cefuroxime for renal impairment, review metronidazole interactions and alcohol advice, and narrow promptly after cultures and source control.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CG188 Gallstone disease diagnosis and management
  • NICE NG253 Suspected sepsis in people aged 16 or over
  • NICE CG174 Intravenous fluid therapy in adults in hospital
  • UKHSA Start smart then focus antimicrobial stewardship

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom